Disseminated invasive aspergillosis in a patient with acute leukaemia

Acta Biomedica de l'Ateneo Parmense

Volumn 77, Issue SUPPL. 2, 2006, Pages 10-13

  Gottfredsson, Magnús ^a   Steingrímsdóttir, Hlíf ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Caspofungin; Combination anti fungal therapy; Invasive aspergillosis; Liposomal amphotericin B; Voriconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; C REACTIVE PROTEIN; CASPOFUNGIN; CEFTAZIDIME; DOXORUBICIN; ERYTHROMYCIN; FLUCONAZOLE; GENTAMICIN; METHOTREXATE; PENICILLIN G; VINCRISTINE; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTEREMIA; BRONCHOSCOPY; CASE REPORT; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; DEATH; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FUNGUS CULTURE; HUMAN; LUNG LAVAGE; MUCOSA INFLAMMATION; NEUTROPENIA; PNEUMONIA; TREATMENT RESPONSE;

AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLOSIS; BACTEREMIA; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE, FUNGAL; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY FAILURE, ACUTE; LEUKEMIA, PRE-B-CELL; LIPOSOMES; LUNG DISEASES, FUNGAL; MEDICAL FUTILITY; METHOTREXATE; MIDDLE AGED; NEUROASPERGILLOSIS; PEPTIDES, CYCLIC; PNEUMONIA, BACTERIAL; PYRIMIDINES; STREPTOCOCCAL INFECTIONS; TRIAZOLES; VINCRISTINE;

EID: 33845288306     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-17.
2. Perea S, Patterson TF. Invasive Aspergillus infections in hematologic malignancy patients. Semin Respir Infect 2002; 17: 99-105.
3. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340: 764-71.
4. Nosari A, Oreste P, Cairoli, R, et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 2001; 68: 231-6.
5. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
6. Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-34.
7. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-402.
8. Singh N, Limaye AP, Forrest G, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006; 81: 320-6.